Ambarella, Inc. financials

SEC pipeline catching up: most recent reported quarter (2026-04-30) isn't incorporated yet — this page is anchored to 2026-01-31 (FY 2026 · 10-K). New filings land within a few weekday pipeline runs.
AMBA CIK 0001280263

Source: EDGAR filings · Built 2026-06-02T02:18:50Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Free Cash Flow 58.01M 23.45M 7.05M 29.04M 29.12M 28.85M
EBITDA -56.94M -100.53M -129.75M -54.32M -15.64M -49.20M
Working Capital 232.33M 199.56M 197.18M 221.17M 177.46M 423.34M
Net Debt -177.58M -139.36M -139.57M -104.91M -159.33M -230.84M
Gross Margin 59.19% 60.50% 60.41% 61.89% 62.72% 60.80%
Operating Margin -21.12% -44.44% -68.25% -21.99% -8.93% -27.43%
Net Margin -19.42% -41.12% -74.81% -19.37% -7.96% -26.81%
Return on Equity (ROE) -12.75% -20.86% -30.26% -10.79% -4.83% -12.59%
Return on Assets (ROA) -9.50% -17.00% -25.76% -9.21% -4.02% -10.43%
Current Ratio 2.31× 2.65× 3.38× 3.65× 2.99× 6.72×
Debt-to-Equity 0.02× 0.01× 0.01× 0.01× 0.02× 0.02×
Effective Tax Rate -2.94% 0.51% -14.06% 7.83% 7.79% -4.33%
Cash Conversion Ratio -0.97× -0.29× -0.11× -0.67× -1.47× -0.52×
Accruals Ratio -0.19× -0.22× -0.29× -0.15× -0.10× -0.16×
SBC % of Revenue 25.09% 37.84% 49.15% 32.93% 26.46% 31.45%
CapEx Coverage 4.74× 3.26× 1.59× 2.93× 4.01× 15.78×
Free Cash Flow Per Share $1.36 $0.57 $0.18 $0.76 $0.80 $0.83

Valuation Metrics

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
P/FCF 47.15× 135.09× 297.45× 118.68× 176.07× 113.44×
FCF Yield 2.12% 0.74% 0.34% 0.84% 0.57% 0.88%
P/S 7.10× 11.30× 9.40× 10.39× 15.75× 15.04×
P/B 4.66× 5.73× 3.80× 5.79× 9.55× 7.06×

Income Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Revenue from Contract with Customer, Excluding Assessed Tax 390.70M 284.87M 226.47M 337.61M 331.86M 222.99M
Cost of Goods and Services Sold 159.44M 112.53M 89.66M 128.67M 123.72M 87.42M
Gross Profit 231.27M 172.33M 136.82M 208.93M 208.13M 135.57M
Research and Development Expense 238.52M 226.11M 215.05M 204.95M 167.34M 140.76M
Selling, General and Administrative Expense 75.27M 72.82M 76.33M 78.24M 70.44M 55.98M
Operating Expenses 313.79M 298.93M 291.38M 283.19M 237.78M 196.74M
Operating Income (Loss) -82.53M -126.59M -154.56M -74.26M -29.64M -61.17M
Income Tax Expense (Benefit) 2.17M -602.00K 20.89M -5.55M -2.23M 2.48M
Net Income (Loss) Attributable to Parent -75.86M -117.13M -169.42M -65.39M -26.41M -59.79M
Earnings Per Share, Basic $-1.78 $-2.84 $-4.25 $-1.70 $-0.72 $-1.72
Weighted Average Number of Shares Outstanding, Basic 42.70M 41.30M 39.88M 38.36M 36.58M 34.68M
Earnings Per Share, Diluted $-1.78 $-2.84 $-4.25 $-1.70 $-0.72 $-1.72
Weighted Average Number of Shares Outstanding, Diluted 42.70M 41.30M 39.88M 38.36M 36.58M 34.68M

Balance Sheet

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Cash and Cash Equivalents, at Carrying Value 191.02M 144.62M 144.91M 113.54M 171.04M 241.27M
Assets, Current 410.27M 320.55M 280.16M 304.63M 266.75M 497.30M
Assets 798.60M 688.97M 657.65M 710.20M 657.54M 573.28M
Liabilities, Current 177.94M 120.99M 82.98M 83.46M 89.28M 73.97M
Liabilities 203.81M 127.56M 97.78M 104.11M 110.37M 98.30M
Stockholders' Equity Attributable to Parent 594.79M 561.41M 559.87M 606.09M 547.18M 474.98M
Common Stock, Shares, Outstanding 43.31M 41.96M 40.52M 39.04M 37.30M 35.55M

Cash Flow Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Net Cash Provided by (Used in) Operating Activities 73.52M 33.84M 19.02M 44.09M 38.80M 30.80M
Payments to Acquire Property, Plant, and Equipment 1.95M
Net Cash Provided by (Used in) Investing Activities -30.49M -40.53M 7.84M -107.30M -119.55M -31.32M
Payments for Repurchase of Common Stock 1.00M 0 0 0 0 1.00M
Net Cash Provided by (Used in) Financing Activities 3.81M 6.40M 4.51M 5.70M 10.53M 10.40M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (AMBA CIK 0001280263), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

CRBP

Corbus Pharmaceuticals Holdings, Inc.

MC

Moelis & Co

TRAK

ReposiTrak, Inc.